GERI-TABS DIN 00436674
Health Canada record
| Active ingredient(s) | METHYLTESTOSTERONE 2 MG; ETHINYL ESTRADIOL 5 MCG; THYROID 16 MG; VITAMIN A 100 UNIT; VITAMIN D 150 UNIT; NICOTINAMIDE 20 MG; THIAMINE HYDROCHLORIDE 2 MG; VITAMIN B2 1 MG; PYRIDOXINE HYDROCHLORIDE .1 MG; VITAMIN B12 .2 MCG; VITAMIN E 2 UNIT; DL-METHIONINE 25 MG; FOLIC ACID .05 MG; IRON PEPTONIZED 6 MG; IODINE .5 MG; CALCIUM 103 MG; MANGANESE SULFATE .03 MG; MAGNESIUM OXIDE .112 MG; PHOSPHORUS 79 MG; CUPRIC SULFATE .06 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1979 |
| Current status date | 26-Mar-2010 |
| Source | Health Canada DPD |
Establishment licence of the holder
Vetoquinol N A Inc. — licence 100448, currently licensed, last inspection rating C (2025-10-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHYLTESTOSTERONE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02338386 | GERI-TONE | SANTE ANIMALE ANIVET INC | Tablet | METHYLTESTOSTERONE 2.0 MG; ETHINYL ESTRADIOL 0.005 MG; THYROID 16 MG; VITAMIN A 100 UNIT; VITAMIN D 150 UNIT; DL-METHIONINE 25 MG; VITAMIN B12 0.2 MCG; NICOTINAMIDE 20 MG; THIAMINE HYDROCHLORIDE 2.0 MG; VITAMIN B2 1.0 MG; PYRIDOXINE HYDROCHLORIDE 0.1 MG; VITAMIN E 2.0 UNIT; FOLIC ACID 0.05 MG; IRON PEPTONIZED 6.0 MG; IODINE 0.5 MG; CALCIUM (CALCIUM PHOSPHATE (DIBASIC)) 103 MG; MANGANESE SULFATE 0.03 MG; MAGNESIUM OXIDE 0.112 MG; PHOSPHORUS (CALCIUM PHOSPHATE (DIBASIC)) 79 MG; CUPRIC SULFATE 0.06 MG | Approved |
| 00005622 | METANDREN 10MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | METHYLTESTOSTERONE 10 MG | Cancelled Post Market |
| 00005630 | METANDREN 25MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | METHYLTESTOSTERONE 25 MG | Cancelled Post Market |
International API supply for METHYLTESTOSTERONE
3 active FDA Drug Master Files.
Request a quote for GERI-TABS